Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain diseases based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Jake Junkil Been, CEO, and Donghyeon Kim, CTO, who developed the next-generation neuro-navigation system.

Major products include brain MRI imaging analysis and interpretation software "Neurophet AQUA", brain PET scan analysis (PET tracer deposition) software "Neurophet SCALE PET", brain electric and magnetic stimulation simulation software "Neurophet tES/TMS Lab", and a brain region of interest analysis research tool "Neurophet SegPlus".

Neurophet has set its top priority to helping patients suffering from brain diseases. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.


Neurophet

As the notification last week, this page will be closed on Oct. 6th. Please visit our new official LinkedIn page and follow us to keep communicate!🙌 
👉 https://lnkd.in/g7bhFEuw

Thank you everyone, for your interest and support!💗 
 
Hope you have enjoyed Neurophet’s news, events, and health related information, etc. so far on our LinkedIn page.  

You might notice that there are two different pages of Neurophet, and we decided to integrate these pages since they could be confusing for users.  
This page will be closed on Oct. 6th, and I’d love to invite you to the new official Neurophet’s LinkedIn page. Please visit and follow our page! 
👉 https://lnkd.in/g7bhFEuw

We promise to continuously provide the latest news and interesting information. Stay tuned for more to come!😊  

[#Neurophet_Conference] 

Neurophet participated in the International Society for Magnetic Resonance in Medicine (ISMRM) JPC 2023 in Japan and introduced the importance and necessity of using brain image analysis software.📊  

Professor Hyun Kook Lim, CMO of Neurophet and head of Catholic Dementia Cognitive Disorder Center, presented why quantification software is needed for brain image analysis and the advantages of using Neurophet AQUA in the medical field.👨‍⚕️ 

Neurophet is actively engaged in sales and marketing activities to supply Neurophet AQUA to the Japanese market. 

Check out the pictures of the conference!  

#Neurophet #ISMRM_JPC_2023 #HyunKookLim #CMO #Japan #Nagano #Luncheon_Seminar #Neurophet_AQUA 

[#World_Alzheimers_Day] 

Every September 21st is World Alzheimer's Day, established by Alzheimer's Disease International (ADI) in collaboration with the World Health Organization (WHO).  

Especially this year, there were many global issues related to dementia. There's no cure for Alzheimer's, but the launch of Alzheimer's treatment #Lecanemab and the revision of Alzheimer’s diagnostic criteria, etc. would become available options to slow down disease progression, to cope with symptoms, to early diagnose and to improve quality of life. 

Neurophet continues to develop and collaborate on technology, for our technology and products could be used in the right place to overcome dementia. 

#Neurophet #World_Alzheimers_Day #Alzheimers #Lecanemab #Alzheimers_treatment  

Developer of AI and cloud-powered care coordination software for stroke. It provides users with a diagnosis support tool with a focus on neurology.

Viz.ai

Competitor in the field of neurology diagnostics.

Yostra Labs

Baymatob

Zeit Medical

Aclarion

Competitor in the field of neurological diagnostics.

Kernel

Inscopix

Empatica

Cumulus Neuroscience

BrainCheck

Ceribell

Octave Bioscience

N.Cer

Neurophet is a company that specializes in the development of advanced software solutions for the healthcare industry, focusing on diagnostic and predictive analytics in the field of neurology.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 15, 2024 12:05 PM	5d576c3e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 15, 2024 12:05 PM	634c05f9
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:NEUROPHET

Neurophet